EPHICACYHEALTHOVYN™ Platform
Schedule a Call →
Demo Viewer
Strategy
DV
Your Compound · Your Indication

Your custom dashboard.

This is the OVYN content studio. Brand-agnostic by default — every dashboard, KPI tile, variant card, and signal you see below would be skinned to your brand and product on day one of an engagement. The data on screen is illustrative. Powered by Ephicacy Health.

— Health & Pharma AI Marketing Platform
The AI-Powered Platform Built for Pharma & Biotech. And the agencies supporting them.
OVYN™ is our proprietary AI platform — built by people who have spent 20+ years inside pharma and biotech commercialization. Not trained on generic internet data. Built from the inside out.
Schedule a Call
Intelligence
Commercial strategy, HCP segmentation, payer landscape, audience signals.
Content Engine
Scientific & brand content, versioned by channel.
Activation
Omnichannel deployment across every touchpoint.
Measurement
Live dashboards, performance analytics, real-time insight.
The category we own
OVYN is the MLR-grade production layer for pharma DTC.
Intelligence · Content Engine · Activation · Measurement — three trademarked layers, one signed-off output.
See the architecture →
PDF
Proof of work · case study
Three verticals. Five weeks. 40% reduction in MLR review cycles.
Anonymized multi-brand longevity portfolio. Real cohort numbers, named platform components, engagement model spelled out. 8 pages.
Download →
In motion with
Active engagements,
pilots, and conversations.
Eternal Longevity
Active · 8 yrs
Your Brand
Evaluation
Genmab
Advisory
Wellness Bureau
Active
Sila Wellness
Active
Track record →
Status legend. ● Active = paying or production-deployed. ● Evaluation = active pitch / pilot scoping. ● Advisory = advisor relationship or evaluation conversation.
47
Brand facts indexed
Real, scales per brand
16
Compliance rules enforced
Per-indication tunable
27
Competitors monitored
Weekly cadence
97.5%
MLR pre-check pass rate
Across regulated workloads
48 hr
Brief → versions
Brief in to channel-ready
8 yr
Operating history
Via Eternal · 3 verticals
Onboarding preview · day-90 state
Once live: every approved variant fans out to channels + lands a record in your Veeva archive
Veeva PromoMats · archive
Connector built during onboarding · 4–6 weeks
Channel deployment · proven
Meta · IG · LinkedIn · SFMC · Google · YouTube · Reddit
Open Sources →
Versions in queue
147
+22 this week
Active across 8 campaigns
MLR pass rate
94%
once data flows
Pre-check catches 88% of flags
Time-to-MLR-ready
3.2d
−4.1 days
Versus illustrative pre-platform baseline
Competitive signals
23
5 high-priority
Last 7 days · Competitor A + generics
Content Engine · last 24 hours

Recent versions

Intelligence

Competitive signal

Competitor A · paid Meta● high · 2h ago
New disease-state campaign live targeting cardiology HCPs. Creative emphasizes 'beyond steroids' positioning.
Generic rilonacept · search● high · 6h ago
Estimated launch volume tracking 14% above forecast. New SEO push on 'rilonacept generic' (1,900 vol/mo).
ChatGPT · GEO scan● high · 9h ago
Compound DT-204 mentioned in 3 of 5 prompts on 'rare cardiology indication treatment.' Competitor A mentioned 4 of 5. We're losing the AI surface.
Pfizer pipeline · DT-387 adjacencymed · 1d ago
Phase 2 readout for IL-1 antagonist in pericarditis adjacent indication. Worth flagging to medical.
Patient forum · Redditmed · 1d ago
23 mentions of 'cost' as primary barrier this week. Up from 8 last week. Caregiver subreddit driving the spike.
Compliance · MLR pre-check rail

How the queue is scoring this week

Fair-balance
passing
42 / 42
All variants carry ISI in the right ratio. Last failure: never.
Disease/treatment language
watch
39 / 42
3 variants flagged for unbranded → branded jump. Auto-rewrite suggested.
Outcome guarantees
passing
42 / 42
No 'cure' / 'guaranteed' / 'best' violations across queue.
MLR risk score · avg
passing
Low
Average 12/100 across our pre-check rail. Internal scoring; spike threshold is 35; nothing close.
Jump to a surface
Generate
Brief in, variants out
Creative engine writes 8–12 versions per brief, MLR-aware, Veeva-formatted, claims-cited.
Open →
Email
Patient drips · HCP eBlasts · Approved Email
SFMC patient + HCP campaigns plus Veeva CRM Approved Email rep-triggered template library. Subject A/B testing built in.
Open →
Compliance
MLR pre-check rail
FDA / OPDP guardrails on every output. Flags caught upstream so MLR cycles compress.
Open →
Discovery
SEO + GEO scoring
Organic search + AI-answer surface coverage. Where Compound DT-204 shows up — and where Competitor A outranks us.
Open →
Intelligence
Competitive watchlist
Standing weekly signal across paid, organic, AI answers, patient forums. Nothing one-shot.
Open →
Performance
Top 25% / bottom 25%
Veeva data flows back. The system learns which angles, formats, audiences performed.
Open →
Sources & deployment
Veeva archive · channel deploys · scraped properties
Approved content auto-archives to PromoMats AND auto-deploys to Meta, IG, TikTok, LinkedIn, SFMC, Google Ads, YouTube, Reddit. One approval, every channel.
Open →
For your team · forward as needed
Exec one-pager
For your CMO
Architecture
Intelligence · Content Engine · Activation · Measurement
Brain Trust
Named clinical + regulatory advisors
Research
Ephicacy Health · published thinking
Trust & Compliance
For your security team
Engagement models
Done-for-you, license, or hybrid
Track record
What's running today
FAQ
26 questions, answered
Forward thisOne click to the right page for whoever you need to loop in.
Exec one-pager → CMOTrust & Compliance → SecurityEngagement → ProcurementTrack record → SkepticFAQ → AnyoneStart a pilot → Action
What's underneathArchitecture · advisors · published thinking.
Architecture Intelligence · Content Engine · Activation · MeasurementBrain Trust Named advisorsResearch Ephicacy Health · published
Talk to us30 minutes with Maha + Zein. No deck, no sales motion. We answer your questions.
Schedule a demo →hello@ephicacyhealth.com
OVYN · Content Studio for Pharma